يعرض 1 - 10 نتائج من 63 نتيجة بحث عن '"Nikos Fersis"', وقت الاستعلام: 1.62s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

    المؤلفون: Carolin C. Hack MD, Peter A. Fasching MD, Tanja Fehm MD, Johann de Waal MD, Mahdi Rezai MD, Bernd Baier MD, Gerold Baake MD, Hans-Christian Kolberg MD, Martin Guggenberger MD, Mathias Warm MD, Nadia Harbeck MD, Rachel Wuerstlein MD, Jörg-Uwe Deuker MD, Peter Dall MD, Barbara Richter MD, Grischa Wachsmann MD, Cosima Brucker MD, Jan W. Siebers MD, Nikos Fersis MD, Thomas Kuhn MD, Christopher Wolf MD, Hans-Walter Vollert MD, Georg-Peter Breitbach MD, Wolfgang Janni MD, Robert Landthaler MD, Andreas Kohls MD, Daniela Rezek MD, Thomas Noesslet MD, Gunnar Fischer MD, Stefan Henschen MD, Thomas Praetz MD, Volker Heyl MD, Thorsten Kühn MD, Thomas Krauss MD, Christoph Thomssen MD, Andre Hohn MD, Hans Tesch MD, Christoph Mundhenke MD, Alexander Hein MD, Claudia Rauh MD, Christian M. Bayer MD, Adib Jacob, Katja Schmidt PhD, Erik Belleville PhD, Peyman Hadji MD, Sara Y. Brucker MD, Diethelm Wallwiener MD, Sherko Kümmel MD, Matthias W. Beckmann MD, Daniela Paepke MD

    المصدر: Integrative Cancer Therapies, Vol 16 (2017)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1534-7354; https://doaj.org/toc/1552-695X

    URL الوصول: https://doaj.org/article/d2a81d21043643fba118f1259ec81715

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    Adjuvante endokrine Therapie beim Mammakarzinom: Was ist der aktuelle Stand?

    المؤلفون: Nicolai Maas, Michael W. Friedrich, Stefan Krämer, Marc Thill, Nikos Fersis

    المصدر: Der Gynäkologe. 52:354-359

    مصطلحات موضوعية: Gynecology, 03 medical and health sciences, medicine.medical_specialty, 0302 clinical medicine, business.industry, 030220 oncology & carcinogenesis, Obstetrics and Gynecology, Medicine, 030212 general & internal medicine, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0e7d71d5dd9e0896d487f2af510a373a
    https://doi.org/10.1007/s00129-019-4426-6

    أضف إلى المفضلة
  3. 3
    Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

    المؤلفون: Hans-Christian Kolberg, Sara Y. Brucker, Diethelm Wallwiener, Markus Wallwiener, Peyman Hadji, Erik Belleville, Carsten Hielscher, Bernhard Volz, Pauline Wimberger, Christoph Thomssen, Diana Lüftner, Michael Untch, Wolfgang Janni, Johannes Ettl, Hans Tesch, Naiba Nabieva, Judith Schwitulla, Jens Huober, Peter A. Fasching, Wolfgang Abenhardt, Andreas Schneeweiss, Matthias Geberth, Michael P. Lux, Volkmar Müller, Florin-Andrei Taran, Christian M. Kurbacher, Andreas D. Hartkopf, Tanja Fehm, Matthias W. Beckmann, Rachel Wuerstlein, Friedrich Overkamp, Lothar Häberle, Nikos Fersis

    المصدر: The Breast. 37:42-51

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Receptor, ErbB-2, medicine.drug_class, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Germany, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Everolimus, Registries, Neoplasm Metastasis, skin and connective tissue diseases, Fulvestrant, Aged, 030219 obstetrics & reproductive medicine, Aromatase inhibitor, Estradiol, Aromatase Inhibitors, business.industry, Cancer, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Tamoxifen, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Surgery, Neoplasm Grading, Receptors, Progesterone, business, medicine.drug, Antihormone therapy

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e357d459577e9ac0652f090e1913d7
    https://doi.org/10.1016/j.breast.2017.10.002

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  4. 4
    Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

    المؤلفون: Sara Y. Brucker, C Brucker, Katja Schmidt, J. de Waal, V. Heyl, T. Praetz, P. Hadji, G. Wachsmann, Daniela Rezek, Peter A. Fasching, A. Jacob, J.-U. Deuker, Christian M. Bayer, Peter Dall, M Warm, G. Baake, Thomas Krauss, T Noesselt, Rachel Wuerstlein, Wolfgang Janni, Hans Tesch, Naiba Nabieva, G. Fischer, C. Wolf, M. Guggenberger, A. Hohn, M. W. Beckmann, G. P. Breitbach, Nadia Harbeck, Hans-Christian Kolberg, Barbara Richter, H.-W. Vollert, A. Kohls, Erik Belleville, Alexander Hein, Sherko Kümmel, R. Landthaler, Diethelm Wallwiener, Lothar Häberle, Nikos Fersis, Mahdi Rezai, B. Baier, C. Thomssen, Claudia Rauh, Christoph Mundhenke, S. Henschen, Thorsten Kühn, J.W. Siebers, S. Kellner, Tanja Fehm

    المصدر: Annals of Oncology. 29:186-192

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, Breast Neoplasms, Early Therapy, Medication Adherence, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, Humans, Prospective Studies, Aged, 030219 obstetrics & reproductive medicine, Aromatase inhibitor, Aromatase Inhibitors, business.industry, Proportional hazards model, Letrozole, Hazard ratio, Hematology, Middle Aged, medicine.disease, Comorbidity, Discontinuation, Postmenopause, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a74a89c7fb8aa3aad2be992a0dcdf13
    https://doi.org/10.1093/annonc/mdx630

    أضف إلى المفضلة
  5. 5
    Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

    المؤلفون: Carolin C. Hack MD, Peter A. Fasching MD, Tanja Fehm MD, Johann de Waal MD, Mahdi Rezai MD, Bernd Baier MD, Gerold Baake MD, Hans-Christian Kolberg MD, Martin Guggenberger MD, Mathias Warm MD, Nadia Harbeck MD, Rachel Wuerstlein MD, Jörg-Uwe Deuker MD, Peter Dall MD, Barbara Richter MD, Grischa Wachsmann MD, Cosima Brucker MD, Jan W. Siebers MD, Nikos Fersis MD, Thomas Kuhn MD, Christopher Wolf MD, Hans-Walter Vollert MD, Georg-Peter Breitbach MD, Wolfgang Janni MD, Robert Landthaler MD, Andreas Kohls MD, Daniela Rezek MD, Thomas Noesslet MD, Gunnar Fischer MD, Stefan Henschen MD, Thomas Praetz MD, Volker Heyl MD, Thorsten Kühn MD, Thomas Krauss MD, Christoph Thomssen MD, Andre Hohn MD, Hans Tesch MD, Christoph Mundhenke MD, Alexander Hein MD, Claudia Rauh MD, Christian M. Bayer MD, Adib Jacob, Katja Schmidt PhD, Erik Belleville PhD, Peyman Hadji MD, Sara Y. Brucker MD, Diethelm Wallwiener MD, Sherko Kümmel MD, Matthias W. Beckmann MD, Daniela Paepke MD

    المصدر: Integrative Cancer Therapies
    Integrative Cancer Therapies, Vol 16 (2017)

    مصطلحات موضوعية: integrative medicine, letrozole, Aromatase Inhibitors, Medizin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antineoplastic Agents, Breast Neoplasms, Middle Aged, Triazoles, information, Postmenopause, breast cancer, Germany, oncology, aromatase inhibitor, Nitriles, Humans, Female, therapy management, Prospective Studies, RC254-282, Research Articles, complementary and alternative medicine, Aged

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5d4228953f1d70f81af0512e555ea5b8
    http://europepmc.org/articles/PMC5739129

    أضف إلى المفضلة
  6. 6
    Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

    المؤلفون: Christian Löhberg, C Brucker, Rachel Wuerstlein, P Gaß, S. Henschen, V. Heyl, Diethelm Wallwiener, Thorsten Kühn, J.W. Siebers, Hans-Christian Kolberg, Daniela Rezek, T. Praetz, A. Hohn, A. Jacob, Nikos Fersis, Johann de Waal, G. Baake, T Noesselt, Christoph Thomssen, Thomas Krauss, M. Guggenberger, Tanja Fehm, B. Baier, Peter A. Fasching, Barbara Richter, G. Fischer, H.-W. Vollert, Christoph Mundhenke, Katja Schmidt, Mahdi Rezai, Matthias W. Beckmann, Thomas Kuhn, Christian M. Bayer, C. Wolf, A. Kohls, Claudia Rauh, Wolfgang Janni, Hans Tesch, G. P. Breitbach, Nadia Harbeck, Peter Dall, Joerg-Uwe Deuker, R. Landthaler, Sherko Kümmel, Mathias Warm, Erik Belleville, Alexander Hein, G. Wachsmann, Sara Y. Brucker, P. Hadji

    المصدر: Breast Care. 11:315-322

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, ddc:618, 030219 obstetrics & reproductive medicine, Adjuvant chemotherapy, business.industry, medicine.medical_treatment, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Medizinische Fakultät, Hormone receptor, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Original Article, Surgery, business, Adjuvant, Hormone

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120dfd9455f4da4141df7be53622f93b
    https://doi.org/10.1159/000452468

    أضف إلى المفضلة
  7. 7
    Cancer Therapy & Research Center/American Association for Cancer Research. Reflexionen nach dem 35. San Antonio Breast Cancer Symposium

    المؤلفون: Nikos Fersis, Michael Friedrich

    المصدر: Geburtshilfe und Frauenheilkunde. 73:262-265

    مصطلحات موضوعية: Gerontology, Oncology, medicine.medical_specialty, Breast cancer, business.industry, Internal medicine, Maternity and Midwifery, medicine, Cancer therapy, Obstetrics and Gynecology, medicine.disease, business, Research center

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ff98fb3bd6b5dea555e05d697ee80b36
    https://doi.org/10.1055/s-0032-1328529

    أضف إلى المفضلة
  8. 8
    Abstract P1-14-05: Phase I/II Trial of primary chemotherapy with non-pegylated liposomal doxorubicin, paclitaxel and lapatinib in patients with HER2-positive, early stage breast cancer

    المؤلفون: D. Elling, D Lampe, M Böhme, T Lantzsch, Antje Belau, Sherko Kümmel, Peter Schmid, Nikos Fersis, J Bischoff, J. Krocker, Bahriye Aktas

    المصدر: Cancer Research. 72:P1-14

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pharmacology, medicine.disease, Lapatinib, Pegylated Liposomal Doxorubicin, chemistry.chemical_compound, Breast cancer, Phase i ii, Paclitaxel, chemistry, Internal medicine, medicine, In patient, Primary chemotherapy, Stage (cooking), business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d6d638a5ab31678be09a7f39b6cf2fae
    https://doi.org/10.1158/0008-5472.sabcs12-p1-14-05

    أضف إلى المفضلة
  9. 9
    Stellenwert der Intervalloperation nach Induktionschemotherapie bei Patientinnen mit fortgeschrittenem epithelialem Ovarialkarzinom: eine retrospektive Studie an der Universitäts-Frauenklinik Heidelberg

    المؤلفون: C. Sohn, C Mayer, E. Bischofs, Thomas Bruckner, E. Anastasiou, Michael Eichbaum, Nikos Fersis

    المصدر: Geburtshilfe und Frauenheilkunde. 71:405-411

    مصطلحات موضوعية: Maternity and Midwifery, Obstetrics and Gynecology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7ba2ab2f0f0bd78c02a23196ba6422ac
    https://doi.org/10.1055/s-0030-1271075

    أضف إلى المفضلة
  10. 10
    3′-Deoxy-3′-[18F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment

    المؤلفون: Roland Bares, Reinhard Vonthein, B. Smyczek-Gargya, Helmut Dittmann, Nikos Fersis, Rainer Kehlbach, Ajnur Jusufoska, Hans Juergen Machulla, Bernhard M. Dohmen, Maren Pritzkow

    المصدر: Nuclear Medicine and Biology. 36:163-169

    مصطلحات موضوعية: Oncology, Fluorine Radioisotopes, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Breast Neoplasms, Docetaxel, S Phase, Breast cancer, In vivo, Cell Line, Tumor, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Doxorubicin, Cell Proliferation, Chemotherapy, Nucleoside analogue, business.industry, Cell growth, medicine.disease, In vitro, cardiovascular system, Cancer research, Molecular Medicine, Female, Taxoids, sense organs, Radiopharmaceuticals, business, Thymidine, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6a9c209d0285e02de421da176e9283
    https://doi.org/10.1016/j.nucmedbio.2008.10.012

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء